Gansu Provincial Cancer Hospital — Lanzhou, Gansu

Public research footprint of Gansu Provincial Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · Gastric Cancer · Unresectable or Metastatic Gastric or Gastroesophageal Junction… · Breast Cancer

Recently updated registry entries

NCT06750094 — A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in… (Recruiting)
NCT07218341 — A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic… (Recruiting)
NCT05111626 — Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab for… (Terminated)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Gansu Provincial Cancer Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.